Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trichloroethylene (TCE) Exposure in an Industrial Population (TCE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00839514
Recruitment Status : Completed
First Posted : February 9, 2009
Last Update Posted : June 7, 2012
Sponsor:
Information provided by (Responsible Party):
John Slevin, University of Kentucky

Tracking Information
First Submitted Date February 6, 2009
First Posted Date February 9, 2009
Last Update Posted Date June 7, 2012
Study Start Date February 2009
Actual Primary Completion Date August 2009   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures Not Provided
Original Primary Outcome Measures Not Provided
Change History
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Trichloroethylene (TCE) Exposure in an Industrial Population
Official Title Evaluation of Parkinson Disease Symptoms in Trichloroethylene Exposed Patients in an Industrial Population
Brief Summary This study is to follow-up with workers from a local company that had exposure to TCE that may have symptoms of Parkinson's disease. We hope to learn more about TCE exposure and Parkinson's disease. Eligible participants will be those who participated in previous research study entitled "Survey of Selected Exposures and Neurologic Symptoms in an Industrial Population"
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Cross-Sectional
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Follow-up with individuals who previously particpated in the research study entitled "Survey of Selected Exposures and Neurologic Symptoms in an Industrial Population"
Condition Parkinson's Disease
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications * Gash DM, Rutland K, Hudson NL, Sullivan PG, Bing G, Cass WA, Pandya JD, Liu M, Choi DY, Hunter RL, Gerhardt GA, Smith CD, Slevin JT, Prince TS. Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity. Ann Neurol. 2008 Feb;63(2):184-92.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: February¬†6,¬†2009)
27
Original Estimated Enrollment Same as current
Actual Study Completion Date August 2009
Actual Primary Completion Date August 2009   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Previous participant in the research study entitled "Survey of Selected Exposures and Neurologic Symptoms in an Industrial Population"

Exclusion Criteria:

  • Not a participant in the research study entitled "Survey of Selected Exposures and Neurologic Symptoms in an Industrial Population"
Sex/Gender
Sexes Eligible for Study: All
Ages Child, Adult, Older Adult
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT00839514
Other Study ID Numbers 08-0301
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party John Slevin, University of Kentucky
Study Sponsor University of Kentucky
Collaborators Not Provided
Investigators
Principal Investigator: John T Slevin, MD University of Kentucky
PRS Account University of Kentucky
Verification Date June 2012